Cargando…

Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)

Detalles Bibliográficos
Autores principales: Seok, Hannah, Sohn, Tae Seo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712223/
https://www.ncbi.nlm.nih.gov/pubmed/31441249
http://dx.doi.org/10.4093/dmj.2019.0130
_version_ 1783446638178598912
author Seok, Hannah
Sohn, Tae Seo
author_facet Seok, Hannah
Sohn, Tae Seo
author_sort Seok, Hannah
collection PubMed
description
format Online
Article
Text
id pubmed-6712223
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-67122232019-09-04 Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86) Seok, Hannah Sohn, Tae Seo Diabetes Metab J Letter Korean Diabetes Association 2019-08 2019-08-20 /pmc/articles/PMC6712223/ /pubmed/31441249 http://dx.doi.org/10.4093/dmj.2019.0130 Text en Copyright © 2019 Korean Diabetes Association http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Seok, Hannah
Sohn, Tae Seo
Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
title Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
title_full Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
title_fullStr Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
title_full_unstemmed Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
title_short Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
title_sort letter: efficacy and safety of voglibose plus metformin in patients with type 2 diabetes mellitus: a randomized controlled trial (diabetes metab j 2019;43;276-86)
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712223/
https://www.ncbi.nlm.nih.gov/pubmed/31441249
http://dx.doi.org/10.4093/dmj.2019.0130
work_keys_str_mv AT seokhannah letterefficacyandsafetyofvogliboseplusmetformininpatientswithtype2diabetesmellitusarandomizedcontrolledtrialdiabetesmetabj20194327686
AT sohntaeseo letterefficacyandsafetyofvogliboseplusmetformininpatientswithtype2diabetesmellitusarandomizedcontrolledtrialdiabetesmetabj20194327686